RB Global, Inc. filings document the regulatory record for a Canadian public company whose common shares trade under RBA and whose business centers on commercial-asset and vehicle marketplaces. The company’s reports cover operating results, gross transaction value, revenue categories, dividends, listed securities and capital-return actions such as share repurchase programs.
RBA filings also include definitive proxy materials and Form 8-K reports covering annual and special meeting votes, director elections, board composition, executive compensation, shareholder proposals and other governance matters. Material-event filings describe financial results, shareholder voting outcomes, capital-structure disclosures and corporate actions affecting the company’s common shares and related rights.
Eric Guerin, Chief Financial Officer of RB Global Inc. (RBA), reported receipt of dividend equivalent rights tied to previously granted restricted share units. The Form 4 discloses two accruals dated 09/18/2025: 32 dividend equivalent rights related to the 2024 RSU grant and 57 dividend equivalent rights related to the 2025 RSU grant. Each dividend equivalent right represents a contingent economic entitlement equal to one RBA common share and becomes exercisable proportionately with the underlying RSUs.
The filing shows the ownership form as direct for both items and lists the amounts of common shares beneficially owned following the transactions as 225 and 83 respectively. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Guerin on 09/22/2025.
Eric Guerin, Chief Financial Officer of RB Global Inc. (RBA), reported receipt of dividend equivalent rights tied to previously granted restricted share units. The Form 4 discloses two accruals dated 09/18/2025: 32 dividend equivalent rights related to the 2024 RSU grant and 57 dividend equivalent rights related to the 2025 RSU grant. Each dividend equivalent right represents a contingent economic entitlement equal to one RBA common share and becomes exercisable proportionately with the underlying RSUs.
The filing shows the ownership form as direct for both items and lists the amounts of common shares beneficially owned following the transactions as 225 and 83 respectively. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Guerin on 09/22/2025.
Nancy Elizabeth King, Chief Technology Officer of RB Global Inc. (RBA), reported accrual and receipt of dividend equivalent rights tied to restricted share unit (RSU) grants. On 09/18/2025 she received 19 dividend equivalent rights related to 2024 RSUs and 13 dividend equivalent rights related to 2025 RSUs, representing the economic equivalent of that many RBA common shares. Following these accruals she beneficially owns 109 shares (associated with the 2024 grant) and 26 shares (associated with the 2025 grant), all held directly. The Form 4 was signed by an attorney-in-fact on 09/22/2025.
Nancy Elizabeth King, Chief Technology Officer of RB Global Inc. (RBA), reported accrual and receipt of dividend equivalent rights tied to restricted share unit (RSU) grants. On 09/18/2025 she received 19 dividend equivalent rights related to 2024 RSUs and 13 dividend equivalent rights related to 2025 RSUs, representing the economic equivalent of that many RBA common shares. Following these accruals she beneficially owns 109 shares (associated with the 2024 grant) and 26 shares (associated with the 2025 grant), all held directly. The Form 4 was signed by an attorney-in-fact on 09/22/2025.
Michael D. Sieger, a director of RB Global Inc. (ticker: RBA), reported on Form 4 that on 09/18/2025 he acquired dividend equivalent rights tied to deferred share units and to a 2025 restricted share unit (RSU) grant. The filing records an acquisition of 6 dividend equivalent rights related to deferred share units and 5 dividend equivalent rights related to 2025 RSUs; each right represents a contingent entitlement to the economic equivalent of one RBA common share and were acquired at a price of $0. The reported ownership form for both items is direct. The form shows 52 and 10 derivative securities beneficially owned following the respective transactions. The filing was signed by an attorney-in-fact on behalf of Mr. Sieger on 09/19/2025.
Michael D. Sieger, a director of RB Global Inc. (ticker: RBA), reported on Form 4 that on 09/18/2025 he acquired dividend equivalent rights tied to deferred share units and to a 2025 restricted share unit (RSU) grant. The filing records an acquisition of 6 dividend equivalent rights related to deferred share units and 5 dividend equivalent rights related to 2025 RSUs; each right represents a contingent entitlement to the economic equivalent of one RBA common share and were acquired at a price of $0. The reported ownership form for both items is direct. The form shows 52 and 10 derivative securities beneficially owned following the respective transactions. The filing was signed by an attorney-in-fact on behalf of Mr. Sieger on 09/19/2025.
Sarah E. Raiss, a director of RB Global, Inc. (RBA), reported acquisition of dividend equivalent rights linked to deferred share units and restricted share units. On 09/18/2025 the filing shows the reporting person received 52 dividend equivalent rights related to deferred share units and 5 dividend equivalent rights related to a 2025 restricted share unit grant. Each dividend equivalent right represents a contingent entitlement to the economic equivalent of one RBA common share and becomes exercisable and payable with the underlying units. After these accruals the report lists 1,904 common shares beneficially owned associated with the deferred share units and 10 common shares beneficially owned associated with the 2025 RSUs. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/19/2025.
Sarah E. Raiss, a director of RB Global, Inc. (RBA), reported acquisition of dividend equivalent rights linked to deferred share units and restricted share units. On 09/18/2025 the filing shows the reporting person received 52 dividend equivalent rights related to deferred share units and 5 dividend equivalent rights related to a 2025 restricted share unit grant. Each dividend equivalent right represents a contingent entitlement to the economic equivalent of one RBA common share and becomes exercisable and payable with the underlying units. After these accruals the report lists 1,904 common shares beneficially owned associated with the deferred share units and 10 common shares beneficially owned associated with the 2025 RSUs. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/19/2025.
RB Global Inc. (RBA) Form 4 shows Director Gregory B. Morrison was allocated 5 dividend equivalent rights tied to the 2025 restricted share unit (RSU) grant, each representing the economic equivalent of one common share. The transaction date is 09/18/2025 and the filing indicates 10 shares beneficially owned following the reported transaction, held directly. The filing was signed by an attorney-in-fact on behalf of Mr. Morrison on 09/19/2025. The explanation clarifies the dividend equivalents accrue with the 2025 RSUs and vest proportionately with those RSUs.
RB Global Inc. (RBA) Form 4 shows Director Gregory B. Morrison was allocated 5 dividend equivalent rights tied to the 2025 restricted share unit (RSU) grant, each representing the economic equivalent of one common share. The transaction date is 09/18/2025 and the filing indicates 10 shares beneficially owned following the reported transaction, held directly. The filing was signed by an attorney-in-fact on behalf of Mr. Morrison on 09/19/2025. The explanation clarifies the dividend equivalents accrue with the 2025 RSUs and vest proportionately with those RSUs.
RB Global Inc. (RBA) Form 4 shows Director Gregory B. Morrison was allocated 5 dividend equivalent rights tied to the 2025 restricted share unit (RSU) grant, each representing the economic equivalent of one common share. The transaction date is 09/18/2025 and the filing indicates 10 shares beneficially owned following the reported transaction, held directly. The filing was signed by an attorney-in-fact on behalf of Mr. Morrison on 09/19/2025. The explanation clarifies the dividend equivalents accrue with the 2025 RSUs and vest proportionately with those RSUs.
Adam DeWitt, a director of RB Global Inc. (RBA), received dividend equivalent rights on 09/18/2025 related to deferred share units and a 2025 RSU grant. The Form 4 reports the accrual and immediate acquisition of 23 dividend equivalent rights tied to deferred share units and 5 dividend equivalent rights tied to 2025 restricted share units; each right represents a contingent economic equivalent to one RBA common share and carries a $0 price. The filing shows the beneficial ownership following these transactions as 503 common shares (for the deferred share unit-related rights) and 10 common shares (for the 2025 RSU-related rights). The Form 4 was signed by an attorney-in-fact on 09/19/2025.
Adam DeWitt, a director of RB Global Inc. (RBA), received dividend equivalent rights on 09/18/2025 related to deferred share units and a 2025 RSU grant. The Form 4 reports the accrual and immediate acquisition of 23 dividend equivalent rights tied to deferred share units and 5 dividend equivalent rights tied to 2025 restricted share units; each right represents a contingent economic equivalent to one RBA common share and carries a $0 price. The filing shows the beneficial ownership following these transactions as 503 common shares (for the deferred share unit-related rights) and 10 common shares (for the 2025 RSU-related rights). The Form 4 was signed by an attorney-in-fact on 09/19/2025.
Form 144 notice filed for RBA (RB Global Inc.) discloses a proposed sale of 7,000 common shares through Fidelity Brokerage Services LLC on the NYSE with an aggregate market value of $831,740 and approximately 185,599,375 shares outstanding. The securities listed were acquired by option granted 02/25/2021 and are recorded as acquired on 09/19/2025, with payment to be made in cash on the sale date.
The filing also reports recent sales by the same person, James J. Jeter: 10,000 shares sold on 08/13/2025 for $1,167,147 and 4,483 shares sold on 09/02/2025 for $521,285.93. The filer affirms no undisclosed material adverse information and includes the standard signature and criminal-penalty notice.
Form 144 notice filed for RBA (RB Global Inc.) discloses a proposed sale of 7,000 common shares through Fidelity Brokerage Services LLC on the NYSE with an aggregate market value of $831,740 and approximately 185,599,375 shares outstanding. The securities listed were acquired by option granted 02/25/2021 and are recorded as acquired on 09/19/2025, with payment to be made in cash on the sale date.
The filing also reports recent sales by the same person, James J. Jeter: 10,000 shares sold on 08/13/2025 for $1,167,147 and 4,483 shares sold on 09/02/2025 for $521,285.93. The filer affirms no undisclosed material adverse information and includes the standard signature and criminal-penalty notice.
RB Global Inc. (RBA) insider sale disclosed. Chief Operations Officer Michael Thomas Steven Lewis reported a sale of 2,151 common shares on 09/12/2025 at a price of $118.15 per share, leaving 0 shares beneficially owned following the transaction. The Form 4 was signed by an attorney-in-fact on 09/15/2025.
RB Global Inc. (RBA) insider sale disclosed. Chief Operations Officer Michael Thomas Steven Lewis reported a sale of 2,151 common shares on 09/12/2025 at a price of $118.15 per share, leaving 0 shares beneficially owned following the transaction. The Form 4 was signed by an attorney-in-fact on 09/15/2025.
Form 144 notice for RBA (RB GLOBAL INC.): The filer intends to sell 2,151 shares of common stock on 09/12/2025 through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $254,140.65. The issuer has 185,599,375 shares outstanding. The shares were acquired on 03/15/2025 by restricted stock vesting from the issuer as compensation. No securities were reported sold by the filer in the past three months. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information.
Form 144 notice for RBA (RB Global, Inc.) reports a proposed sale of 4,483 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $521,285.93 against 185,599,375 shares outstanding. The securities were acquired under an option (granted 03/15/2022) and marked as acquired on 09/02/2025 with cash payment. The filing also discloses a recent sale by the same person of 10,000 common shares on 08/13/2025 for gross proceeds of $1,167,147.00. The filer certifies no undisclosed material adverse information but the document omits the filer CIK/CCC and the issuer address details.